Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
3 clinical trials · Condition
◉ Watch Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
| Record | Firm | Date |
|---|---|---|
| Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL (NCT05149170) | Chinese Academy of Medical Sciences | 2021-10-01 |
| PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma (NCT02085655) | Huiqiang Huang | 2013-04-25 |
| Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma (NCT01238159) | Samsung Medical Center | 2010-08-01 |
Track Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type automatically
Every clearance here is in the API, with alerts when new ones post.